(Q36637898)

15 August 2017

Shengmai injection, a traditional chinese patent medicine, for intradialytic hypotension: a systematic review and meta-analysis (English)

1 reference

15 August 2017

Chao-Yang Chen

1

1 reference

15 August 2017

Ling-Yan Lu

2

1 reference

15 August 2017

Peng Chen

3

1 reference

15 August 2017

Kang-Ting Ji

4

1 reference

15 August 2017

Jia-Feng Lin

5

1 reference

15 August 2017

Peng-Lin Yang

6

1 reference

15 August 2017

Ji-Fei Tang

7

1 reference

15 August 2017

Yan Wang

8

1 reference

15 August 2017

7 February 2013

1 reference

Evidence-based Complementary and Alternative Medicine

15 August 2017

1 reference

15 August 2017

2013

1 reference

15 August 2017

703815

1 reference

Creative Commons Attribution 3.0 Unported

15 August 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

Shengmai (a traditional Chinese herbal medicine) for heart failure

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

Intradialytic hypotension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

Control of core temperature and blood pressure stability during hemodialysis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

Korean red ginseng improves blood pressure stability in patients with intradialytic hypotension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

Amyloid-beta-induced cytotoxicity of PC-12 cell was attenuated by Shengmai-san through redox regulation and outgrowth induction.

28 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F703815

Long-term treatment with shengmai san-derived herbal supplement (Wei Kang Su) enhances antioxidant response in various tissues of rats with protection against carbon tetrachloride hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F703815

Shengmai San, a Chinese herbal medicine protects against rat heat stroke by reducing inflammatory cytokines and nitric oxide formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F703815

Diagnostic fragment-ion-based extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI- IT-TOF/MS: Shengmai injection as

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F703815

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F703815

A trial design that generates only ''positive'' results.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

Effects of shengmai for injection on cardiogenic shock

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582050

Clinical Trial Registration

20 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F703815

Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F703815

Preventing dialysis hypotension: a comparison of usual protective maneuvers

21 January 2018

1 reference

12 December 2020

[A study on the literature on sheng mai powder of past dynasties]

1 reference

12 December 2020

K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients

1 reference

12 December 2020

Recent advances in the prevention and management of intradialytic hypotension

1 reference

12 December 2020

Effect of Shengmai Injection on cardiac function and inflammatory reaction in patients with acute coronary syndrome

1 reference

12 December 2020

[Effect of shengmai injection on the fatality rate of patients with acute myocardial infarction: a systematic review]

1 reference

12 December 2020

[Impact of shengmal injection on changes of immunological function in patients after cardiopulmonary bypass]

1 reference

12 December 2020

Study on the radical scavengers in the traditional Chinese medicine formula shengmai san by HPLC-DAD coupled with chemiluminescence (CL) and ESI-MS/MS

1 reference

12 December 2020

A randomized, controlled trial of albumin versus saline for the treatment of intradialytic hypotension

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/703815

1 reference

15 August 2017

1 reference

15 August 2017

1 reference